J. Chaitow

发表

Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23.

B. Kerr, L. Adès, D. Cass, 1998, Journal of medical genetics.

Consensus-based recommendations for the management of juvenile localised scleroderma

N. Wulffraat, S. Vastert, T. Constantin, 2019, Annals of the rheumatic diseases.

Localized scleroderma in childhood is not just a skin disease.

C. Wouters, P. Woo, B. Athreya, 2005, Arthritis and rheumatism.

Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study

A. Tong, D. Singh-Grewal, K. Manera, 2021, BMJ Open.

A feasibility study of the effect of intra-articular corticosteroid injection on isokinetic muscle strength in children with juvenile idiopathic arthritis.

D. Singh-Grewal, D. McKay, C. Broderick, 2013, Pediatric exercise science.

Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape.

D. Sillence, C. Cowell, E. Wiltshire, 2008, The Journal of rheumatology.

Coexistent MEFV and CIAS1 mutations manifesting as familial Mediterranean fever plus deafness

J. Christodoulou, D. Singh-Grewal, I. Aksentijevich, 2007, Annals of the rheumatic diseases.

Effectiveness of preformed foot orthoses in reducing lower limb pain, swollen and tender joints and in improving quality of life and gait parameters in children with juvenile idiopathic arthritis: a randomised controlled trial (Protocol)

D. Singh-Grewal, A. Coda, D. Santos, 2017, BMJ Paediatrics Open.

Psychosocial functioning in children and young adults with juvenile arthritis.

G. Champion, J. Ungerer, J. Chaitow, 1988, Pediatrics.

A11: Assessment of Radiographic Progression in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2‐Year Data From CHERISH

A. Martini, R. Burgos-Vargas, D. Lovell, 2014 .

Consensus-based recommendations for the management of juvenile systemic sclerosis.

N. Wulffraat, S. Vastert, T. Constantin, 2020, Rheumatology.

Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency.

J. Center, S. Tangye, T. Phan, 2017, The Journal of allergy and clinical immunology.

Physical Examination Tool for Swollen and Tender Lower Limb Joints in Juvenile Idiopathic Arthritis: A Pilot Diagnostic Accuracy Study

D. Singh-Grewal, A. Coda, D. Santos, 2022, International journal of environmental research and public health.

Current management of juvenile arthritis

J. Chaitow, 1986, Indian journal of pediatrics.

Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy.

G. Ambler, R. Ouvrier, M. Rogers, 2005, The Journal of rheumatology.

Changing biological disease modifying treatment for paediatric uveitis in the real world

K. Phan, P. McCluskey, C. L. Nguyen, 2019, Clinical & experimental ophthalmology.

Primary suppurative myositis.

J. Chaitow, E. Broadfoot, 1981, Australasian radiology.

The musculoskeletal complications of cystic fibrosis

R. Howman-Giles, P. Asperen, J. Chaitow, 1998, Journal of paediatrics and child health.

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data

R. Schneider, P. Woo, A. Martini, 2011, Pediatric Rheumatology.

TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: EFFICACY DATA FROM THE PLACEBO-CONTROLLED 12-WEEK PART OF THE PHASE III TENDER TRIAL

R. Schneider, P. Woo, A. Martini, 2011 .

Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5′-phosphate availability

D. Sillence, C. Ellaway, S. Balasubramaniam, 2010, Journal of Inherited Metabolic Disease.

Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial

C. Wouters, Y. Zhang, E. Alexeeva, 2021, The Lancet.

PFAPA: Periodic Fever, Aphthous Ulceration, Pharyngitis, Adenitis

J. Chaitow, 2019, Periodic and Non-Periodic Fevers.

Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing.

T. Andrews, V. Pascual, C. Goodnow, 2014, Arthritis & rheumatology.

Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial

J. Frane, H. Brunner, F. Zulian, 2018, The Journal of Rheumatology.

Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial

J. Frane, R. Schneider, B. Myones, 2015, Arthritis & rheumatology.

Fundamental movement skills, physical fitness and physical activity among Australian children with juvenile idiopathic arthritis

D. Singh-Grewal, N. Henschke, G. Hulsegge, 2014, Journal of paediatrics and child health.

Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults With Systemic Lupus Erythematosus

J. Craig, A. Tong, Ming-Wei Lin, 2016, Arthritis care & research.

Identification of a pathogenic variant in TREX1 in early-onset cerebral SLE by whole-exome sequencing.

T. Andrews, V. Pascual, M. Field, 2016, Pathology.

Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

C. Wouters, A. Martini, R. Burgos-Vargas, 2016, The Journal of Rheumatology.

Functional Ability and Health‐Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis

Bin Huang, A. Martini, D. Siri, 2020, Arthritis care & research.

Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

K. Minden, C. Wouters, E. Alexeeva, 2023, The Lancet.

Australian Paediatric Rheumatology Group standards of care for the management of juvenile idiopathic arthritis

D. Singh-Grewal, J. Munro, J. Akikusa, 2014, Journal of paediatrics and child health.

Thalidomide neuropathy in childhood

M. Ryan, H. Jones, B. Darras, 2005, Neuromuscular Disorders.